Twinrab 600IU Injection

Twinrab 600IU is an injection medication containing miromavimab and docaravimab, active ingredients in the monoclonal antibody (mAb) class. It is recommended as a post-exposure prevention to stop the infection of rabies in those who have been exposed to the virus. It is administered in conjunction with the rabies vaccination.
The virus is known as rabies, which causes brain inflammation. It can infect pet animals and even humans if they are bit or scratched by animals that carry viruses, like bats, dogs, or other animals. Although it’s fatal, it can be prevented.
Before beginning the treatment, consult your medical professional and discuss allergies with similar therapies. After and during the procedure, watch for any possible adverse reactions. The injection is safe for use in children. Consult your doctor if you are nursing or pregnant before using twinrab 600IU.